Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts

W Schorb1, T C Peeler, N N Madigan

  • 1Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822.

Insights

Angiotensin II triggers tyrosine phosphorylation in rat cardiac fibroblasts, identifying key proteins like p44MAPK, p125FAK, and SHC. This suggests angiotensin II

Area of Science:

  • Cardiovascular Biology
  • Cell Signaling
  • Molecular Cardiology

Background:

  • Angiotensin II acts as a growth factor in rat cardiac fibroblasts.
  • Signaling pathways mediating angiotensin II-induced fibroblast growth require elucidation.

Purpose of the Study:

  • To investigate whether angiotensin II stimulates protein tyrosine phosphorylation in cardiac fibroblasts.
  • To identify specific tyrosine-phosphorylated proteins in response to angiotensin II.

Main Methods:

  • Immunoblot analysis to detect tyrosine phosphorylation.
  • Treatment with angiotensin II and platelet-derived growth factor BB.
  • Pertussis toxin pretreatment and protein kinase C downregulation.

Main Results:

  • Angiotensin II rapidly induced tyrosine phosphorylation of 125, 95, 46-60, and 44 kDa proteins.
  • Specific identification of tyrosine-phosphorylated p44MAPK, p125FAK, p46SHC, and p56SHC.
  • Angiotensin II-induced phosphorylation was partially blocked by pertussis toxin.

Conclusions:

  • Angiotensin II-induced tyrosine phosphorylation is involved in mitogenic signaling pathways in cardiac fibroblasts.
  • p46SHC and p56SHC may be common tyrosine kinase substrates in growth factor signaling.
  • This study elucidates key molecular events in angiotensin II-mediated cardiac fibroblast growth.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...